Boulder, CO, United States of America

Paul R Carlson

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cogent Biosciences, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul R Carlson. Retrieved from https://idiyas.com/inventor/paul-r-carlson-bca5ay67

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 20.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paul R. Carlson: Innovator in Pharmaceutical Chemistry

Introduction

Paul R. Carlson is a notable inventor based in Boulder, Colorado. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of PI3K inhibitors. His work focuses on compounds that have the potential to treat various diseases effectively.

Latest Patents

Paul R. Carlson holds 1 patent related to PI3K inhibitors. The patent describes a compound with a specific structure, including stereoisomers and pharmaceutically acceptable salts. The pharmaceutical composition comprising these compounds and their applications in treating diseases are also detailed in the patent.

Career Highlights

Paul is currently associated with Cogent Biosciences, Inc., where he continues to advance his research in pharmaceutical innovations. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.

Collaborations

Throughout his career, Paul has collaborated with talented individuals such as Payal Chatterjee and Mark Joseph Chicarelli. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Paul R. Carlson's contributions to pharmaceutical chemistry, particularly through his patent on PI3K inhibitors, highlight his role as an influential inventor in the industry. His ongoing work at Cogent Biosciences, Inc. continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…